4-Aryliden-2-methyloxazol-5(4H)-one as a new scaffold for selective reversible MAGL inhibitors.

about

Development of terphenyl-2-methyloxazol-5(4H)-one derivatives as selective reversible MAGL inhibitors.A patent review of Monoacylglycerol Lipase (MAGL) inhibitors (2013-2017).

P2860

Q47763157-B4959921-188A-4AD0-8CC2-B8CFEE221432 Q48155432-F9B72605-FF90-4F87-8049-714CF5065448

P2860

4-Aryliden-2-methyloxazol-5(4H)-one as a new scaffold for selective reversible MAGL inhibitors.

Item

http://www.wikidata.org/entity/Q38911009

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

4-Aryliden-2-methyloxazol-5(4H ...... ve reversible MAGL inhibitors.

@en

type

Item

label

4-Aryliden-2-methyloxazol-5(4H ...... ve reversible MAGL inhibitors.

@en

prefLabel

4-Aryliden-2-methyloxazol-5(4H ...... ve reversible MAGL inhibitors.

@en

P1476

4-Aryliden-2-methyloxazol-5(4H ...... ve reversible MAGL inhibitors.

@en

P2093

Adriano Martinelli

http://www.w3.org/2001/XMLSchema#string

Filippo Minutolo

http://www.w3.org/2001/XMLSchema#string

Marco Macchia

http://www.w3.org/2001/XMLSchema#string

Vittorio Bordoni

http://www.w3.org/2001/XMLSchema#string

P2860

Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effects

The endocannabinoid system as an emerging target of pharmacotherapy

Therapeutic potential of monoacylglycerol lipase inhibitors

Structural basis for human monoglyceride lipase inhibition

Crystal Structure of Fatty Acid Amide Hydrolase Bound to the Carbamate Inhibitor URB597: Discovery of a Deacylating Water Molecule and Insight into Enzyme Inactivation

Chronic monoacylglycerol lipase blockade causes functional antagonism of the endocannabinoid system.

Improved protein-ligand docking using GOLD

Use of an inhibitor to identify members of the hormone-sensitive lipase family.

Monoacylglycerol lipase regulates a fatty acid network that promotes cancer pathogenesis.

Inhibition of endocannabinoid catabolic enzymes elicits anxiolytic-like effects in the marble burying assay.

P304

137-146

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/14756366.2015.1010530

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2015-02-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25669350

http://www.w3.org/2001/XMLSchema#string

4-Aryliden-2-methyloxazol-5(4H)-one as a new scaffold for selective reversible MAGL inhibitors.

about

P2860

P2860

4-Aryliden-2-methyloxazol-5(4H)-one as a new scaffold for selective reversible MAGL inhibitors.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698